Dicerna Pharma Stock Price (NASDAQ:DRNA)

Add to My Stocks
$15.52 $0.6 (4.02%) DRNA stock closing price Aug 20, 2018 (Closing)
Prev Close* : $14.92
Market Cap:
Day Low: $14.97
52 Week Low: $2.69
Open: $15.06
Volume: -
Day High: $15.69
52 Week High: $16.32

Latest Stock Market News

Latest Articles

Dicerna Pharma News - From Partners

DRNA Stockcharts

View DRNA PE ratio, PS ratio stocks charts and compare with peers.
DRNA Chart
Note: Compare Dicerna Pharma stock price history with the index and industry peers.

Dicerna Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Dicerna Pharma Returns

(return on equity)

Dicerna Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

DRNA Industry Peers

Company Price Change (%)
Rocket Pharmact (RCKT)20.320.3 (1.5%)
Tobira Therapeutics Inc (TBRA)42.090 (0%)
Raptor Pharma (RPTP)90 (0%)
Arbutus Biopharma (ABUS)8.80.3 (3.3%)
Marina Biotech (MRNA)0.670 (0%)
Regulus Therapeutics (RGLS)0.270.02 (6.9%)
Amgen (AMGN)197.560.14 (0.07%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
China Biologic Products (CBPO)1008.01 (8.71%)
Xoma (XOMA)16.730.91 (5.75%)
ELOXX PHARMACT (ELOX)12.520.57 (4.77%)
Acadia Pharma (ACAD)13.570.54 (4.14%)
Prothena (PRTA)15.10.59 (4.07%)
Dicerna Pharma (DRNA)15.520.6 (4.02%)
MannKind (MNKD)1.110.04 (3.74%)
Top gainers from Medical-Biomed-Genetics industry
* As of Aug 21, 2018
CompanyPriceChange (%)
Exelixis (EXEL)17.691.51 (7.86%)
Array BioPharma (ARRY)13.380.72 (5.11%)
Mirati Therapeutics (MRTX)56.953 (5%)
Agenus (AGEN)1.590.08 (4.79%)
Insmed (INSM)20.110.88 (4.19%)
Retrophin (RTRX)27.361.14 (4%)
IOVANCE BIOTHPT (IOVA)14.350.55 (3.69%)
Top losers from Medical-Biomed-Genetics industry
* As of Aug 21, 2018

Dicerna Pharmaceuticals Inc Stock News - Partner Headlines

Dicerna Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues2.27M----
Net Income-60.04M-59.51M-62.83M-47.93M-18.51M
Total Operating Expense62.86M60.03M63.21M45.09M17.37M
View Dicerna Pharma income statement
balance sheet20172016201520142013
Total Assets120.88M51.25M100.02M103.6M49.79M
Total Liabilities19.64M10.04M9M5.26M8.46M
Shareholders Equity101.23M41.2M91.02M98.34M41.32M
View Dicerna Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-2.7M-3.44M1.38M6.14M
Net Cash from (used by) Operating Activities-45.32M-48.74M-48.79M-34.76M-10.94M
Increase (Decrease) in Prop Plant And Equipment-0.13M-0.44M-1.13M-2.01M-0.41M
View Dicerna Pharma cash flow statement

Dicerna Pharma Stock Message Board

An investor needs to spend $15.52 to buy DRNA stock, as the closing Dicerna Pharma stock price is $15.52. The total market value as denoted by $790.01M for Dicerna Pharma, is the market value of the company's outstanding shares. Dicerna Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of Dicerna Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 198,438 on the last trading day, as is evident from Dicerna Pharma stock chart, and DRNA stock quote data. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Dicerna Pharma does not pay dividends. To check the historical stock price movement, all time high, and all time low of DRNA, view Dicerna Pharma stock price history.